Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

The Searle Company Ltd (SEAR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
57.06 -0.21    -0.37%
26/04 - Closed. Currency in PKR ( Disclaimer )
Type:  Equity
Market:  Pakistan
ISIN:  PK0061701014 
S/N:  SEARL
  • Volume: 7,440,360
  • Bid/Ask: 57.04 / 57.06
  • Day's Range: 56.80 - 58.33
The Searle Company 57.06 -0.21 -0.37%

The Searle Company Ltd Company Profile

 
Get an in-depth profile of The Searle Company Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

2716

Equity Type

ORD

The Searle Company Limited is a Pakistan-based company, which is principally engaged in the manufacture of pharmaceutical and other consumer products. The Company's product portfolio in the pharmaceutical range includes therapeutic areas, such as cardiovascular, respiratory care, gastroenterology, pain management, central nervous system (CNS), orthocare, neuropsychiatry, probiotics, antibiotics, and nutritional care. Its pharmaceutical products Neubrol, Neubrol Forte, Hydryllin, Extor, Tramal, Peditral, Metrozine, Sustac, Ezium, Gravinate, Spiromide, Dextop, Metodine, Rotec, Metodine DF, Selanz, Relispa, Lumark, Decadron, Venofer, Aldomet, Sinemet, Noroxin, Ferinject, Janumet, and Maltofer, among others. Its consumer products include Enfagrow A+, Canderel, and Vitamin Water, among others. It also focuses on specialty generic branded portfolios and targeting differentiated products. Its subsidiaries include IBL HealthCare Limited, Searle Pharmaceuticals (Private) Limited, and others.

Contact Information

Address One IBL Centre Plot # 1, 2nd Floor
Block 7 & 8, D.M.C.H.S Tipu Sultan Road, Off Shahra-e-Faisal Karachi,75350
Pakistan
Phone 92 21 371 70200
Fax 92 21 371 70224

Top Executives

Name Age Since Title
Adnan Asdar Ali - 2011 Non-Executive Chairman
Shaista Khaliq Rehman - 2019 Independent Director
Munis Abdullah - 2021 Non-Executive Director
Syed Nadeem Ahmed - 2015 CEO & Executive Director
Zubair Razzak Palwala - 2013 Group Director of Banking Relations & Corporate Affairs, Company Secretary and Executive Director
Faiza Abdulla - 2023 Director
Muhammad Zubair Haider Shaikh - 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SEAR Comments

Write your thoughts about The Searle Company Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email